相似文献
1
The Hallmarks of Predictive Oncology.
Cancer Discov. 2025 Feb 7;15(2):271-285. doi: 10.1158/2159-8290.CD-24-0760.
2
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives.
Ann Oncol. 2025 Apr 28. doi: 10.1016/j.annonc.2025.03.006.
3
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association.
Circ Genom Precis Med. 2025 Apr;18(2):e000097. doi: 10.1161/HCG.0000000000000097. Epub 2025 Feb 24.
4
PDX models for functional precision oncology and discovery science.
Nat Rev Cancer. 2025 Mar;25(3):153-166. doi: 10.1038/s41568-024-00779-3. Epub 2024 Dec 16.
5
A precision immuno-oncology turn? Hybridizing cancer genomics and immunotherapy through neoantigens-based adoptive cell therapies.
Soc Stud Sci. 2025 Aug;55(4):565-590. doi: 10.1177/03063127241303720. Epub 2024 Dec 15.
6
Shareable artificial intelligence to extract cancer outcomes from electronic health records for precision oncology research.
Nat Commun. 2024 Nov 12;15(1):9787. doi: 10.1038/s41467-024-54071-x.
7
Applications of artificial intelligence multiomics in precision oncology.
J Cancer Res Clin Oncol. 2023 Jan;149(1):503-510. doi: 10.1007/s00432-022-04161-4. Epub 2022 Jul 7.
8
Artificial Intelligence in cancer epigenomics: a review on advances in pan-cancer detection and precision medicine.
Epigenetics Chromatin. 2025 Jun 14;18(1):35. doi: 10.1186/s13072-025-00595-5.
9
From Mutation to Prognosis: AI-HOPE-PI3K Enables Artificial Intelligence Agent-Driven Integration of PI3K Pathway Data in Colorectal Cancer Precision Medicine.
Int J Mol Sci. 2025 Jul 5;26(13):6487. doi: 10.3390/ijms26136487.
10
Role of smartphone devices in precision oncology.
J Cancer Res Clin Oncol. 2023 Jan;149(1):393-400. doi: 10.1007/s00432-022-04413-3. Epub 2022 Oct 17.
本文引用的文献
1
A context-aware deconfounding autoencoder for robust prediction of personalized clinical drug response from cell-line compound screening.
Nat Mach Intell. 2022 Oct;4(10):879-892. doi: 10.1038/s42256-022-00541-0. Epub 2022 Oct 17.
2
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group.
JCO Precis Oncol. 2024 Apr;8:e2300687. doi: 10.1200/PO.23.00687.
3
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors.
Nat Cancer. 2024 Jul;5(7):996-1009. doi: 10.1038/s43018-024-00740-1. Epub 2024 Mar 5.
4
All models are wrong and yours are useless: making clinical prediction models impactful for patients.
NPJ Precis Oncol. 2024 Feb 28;8(1):54. doi: 10.1038/s41698-024-00553-6.
5
Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress.
Cancer Discov. 2024 Mar 1;14(3):508-523. doi: 10.1158/2159-8290.CD-23-0641.
6
Cancer drug sensitivity prediction from routine histology images.
NPJ Precis Oncol. 2024 Jan 6;8(1):5. doi: 10.1038/s41698-023-00491-9.
7
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.
JCO Clin Cancer Inform. 2023 Sep;7:e2300070. doi: 10.1200/CCI.23.00070.
8
Worldwide AI ethics: A review of 200 guidelines and recommendations for AI governance.
Patterns (N Y). 2023 Oct 13;4(10):100857. doi: 10.1016/j.patter.2023.100857.
9
Molecular response assessment using circulating tumor DNA (ctDNA) in advanced solid tumors.
Br J Cancer. 2023 Dec;129(12):1893-1902. doi: 10.1038/s41416-023-02445-1. Epub 2023 Oct 3.
10
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers.
Cancers (Basel). 2023 Aug 8;15(16):4026. doi: 10.3390/cancers15164026.
Zotero 插件